Prevention of venous thromboembolism in total knee and hip replacement

Circulation

Volumn 125, Issue 17, 2012, Pages 2151-2155

  Warwick, David ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; COUMADIN JANTOVEN; DABIGATRAN; DABIGATRAN ETEXILATE; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; TINZAPARIN; UNCLASSIFIED DRUG; WARFARIN;

AGED; ARTICLE; BLEEDING; BONE GRAFT; CASE REPORT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HIP ARTHROPLASTY; HIP PAIN; HUMAN; ILIAC CREST; LEG THROMBOSIS; META ANALYSIS (TOPIC); OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS LOOSENING; RISK ASSESSMENT; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

AGED; ANESTHESIA, CONDUCTION; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIP PROSTHESIS; HUMANS; MORPHOLINES; OBESITY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PREMEDICATION; PROSTHESIS FAILURE; RECURRENCE; REOPERATION; RISK; RISK FACTORS; STOCKINGS, COMPRESSION; THIOPHENES; VENOUS THROMBOEMBOLISM;

EID: 84860317090     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.055731     Document Type: Article

References (17)

1. Parvizi J. Does excessive anticoagulation predispose to peri-prosthetic infection? Arthroplasty. 2007;22:24-28.
2. Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Rel Res. 2008;466:714-721.
3. Sachdeva A, Dalton M, Amaragiri SV, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010: CD001484.
4. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-453S.
5. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P III, Haralson RH III, Watters WC III. American Academy of Orthopaedic Surgeons clinical practice guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am. 2009:-91:1756-1757.
6. NICE Clinical Guideline 92 (2010): reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital Available at http://www.nice.org.uk/guidance/index.jsp? action-byID&o-12695. Accessed October 27, 2011.
7. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (a review.) Cochrane Database Syst Rev. 2008:CD005258.
8. Nicolaides AN, Breddin HK, Carpenter P, Coccheri S, Conard J, De Stefano V, Elkoofy N, Gerotziafas G, Guermazi S, Haas S, Hull R, Kalodiki E, Kristof V, Michiels JJ, Myers K, Pineo G, Prandoni P, Romeo G, Samama MM, Simonian S, Xenophonthos S. Prevention and treatment of venous thromboembolism: International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006;25:101-161.
9. Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, Baigent C. Towards evidence based guidelines for the prevention of venous thromboembolism: systematic review of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess. 2005;49:1-78.
10. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833-1840.
11. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM; ADVANCE-3 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363:2487-2498.
12. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P; ADVANCE-2 investigators. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010;375:807-815.
13. Warwick D, Roschensher N. The "critical thrombosis period" in major orthopedic surgery: when to start and when to stop prophylaxis. Clin Appl Thromb Hemost. 2010;16: 394-405.
14. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, Turibio FM. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events. J Bone Joint Surg. 2007;89B:799-807.
15. Warwick DJ, Dahl OE, Fisher WD. Orthopaedic thromboprophylaxis: limitations of current guidelines. J Bone Joint Surg Br. 2008;90:127-132.
16. Eikelboom JW. American Academy of Orthopaedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009;135:513-520.
17. Preventing venous thromboembolic disease in patients underoing elective hip and knee arthroplasty: evidence-based guideline and evidence report. http://www.aaos.org/Research/guidelines/VTE/VTE-full-guideline.pdf. Accessed November 19, 2011.